| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5826290 | Current Opinion in Pharmacology | 2013 | 7 Pages |
Abstract
⺠Therapies targeting fibroblasts in RA are a certainty. ⺠These therapies may succeed in treating existing biologic 'non-responders'. ⺠Fibroblast therapies have the potential to modify disease persistence. ⺠Novel fibroblast markers developed in cancer and immunology will provide a new generation of specific treatments. ⺠More specific drugs that do not target leukocytes are likely to cause less bone marrow suppression and infection.
Related Topics
Life Sciences
Neuroscience
Cellular and Molecular Neuroscience
Authors
Andrew Filer,